FLERIEFlerie AB (publ)
19.70SEK-0.25%Mkt Cap: 163.37M $P/E:

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications …

Key Statistics

Company
Market Cap163.37M $
Enterprise Value134.71M $
Revenue (TTM)-535.65K $
Gross Profit-2.46M $
Net Income (TTM)-72.40M $
Revenue/Share-0.0062 USD
Last Price19.70 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0022447348
Valuation
P/E (Trailing)
P/E (Forward)-47.32
PEG
EV/EBITDA-34.95
EV/Revenue-251.48
P/S-300.35
P/B0.50
EPS (TTM)-9.48
EPS (Forward)-0.41
52W Range
19.053% of range38.63
52W High38.63 SEK
52W Low19.05 SEK
Profitability
Gross Margin0.00%
Oper. Margin-746.15%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-22.41%
ROA-22.28%
Growth
Revenue Growth-85.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-2.69M $
CapEx (TTM)
FCF Margin490.84%
FCF Yield-1.61%
Net Debt-29.08M $
Net Debt/EBITDA7.54
Balance Sheet
Debt/Equity0.00
Current Ratio66.45
Quick Ratio38.05
Book Value/Sh39.15 SEK
Cash/Share3.526 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split8:7
Split DateMay 15, 2026
Analyst Consensus
Rating
Target (Mean)26.00 SEK
Upside (mean)+32.0%
Target Range26.00 SEK26.00 SEK
# Analysts1
Ownership
Shares Out.86.70M
Float22.43M
Insiders74.93%
Institutions15.21%
Technical
SMA 5020.40 (-3.5%)
SMA 20027.14 (-27.4%)
Beta-0.43
S&P 52W Chg18.16%
Avg Vol (30d)21.76K
Avg Vol (10d)13.28K
Technical Indicators
RSI (14)41.6
MACD-0.2431
MACD Signal-0.2281
MACD Hist.-0.0150
BB Upper20.84 SEK
BB Middle20.18 SEK
BB Lower19.52 SEK
BB Width6.50%
ATR (14)0.6266 SEK
Vol Ratio (20d)8.04x